BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Telehealth credited with boosting effectiveness of care for opioid-use disorder

Oct. 30, 2023
By Mark McCarty
Advocates of expanded use of telehealth in the U.S. may believe they have an unfairly high evidentiary bar to meet to bring payers on board, but that evidentiary requirement just received support from the National Institutes of Health (NIH).
Read More
Man talking into smartphone

Gwangju Institute of Science and Technology researchers use A-TAPT to screen vocal vibrations for disease

Oct. 30, 2023
By Marian (YoonJee) Chu
South Korean researchers from the Gwangju Institute of Science and Technology (GIST) have penned a “groundbreaking” adversarial task adaptive pretraining (A-TAPT) model that could improve the accuracy of analyzing vocal cord vibrations for medical conditions.
Read More

Appointments and advancements for Oct. 30, 2023

Oct. 30, 2023
New hires and promotions in the med-tech industry, including: B. Braun, Evident Vascular.
Read More

Financings for Oct. 30, 2023

Oct. 30, 2023
Med-tech firms raising money in public or private financings, including: Brainbox.
Read More

In the clinic for Oct. 30, 2023

Oct. 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Precision Diabetes.
Read More

Other news to note for Oct. 30, 2023

Oct. 30, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Foxo Technologies, Integrum, Lumiradx, Seastar Medical.
Read More

Regulatory actions for Oct. 30, 2023

Oct. 30, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alivedx, Neurotrigger.
Read More

Regulatory actions for Oct. 27, 2023

Oct. 27, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cordance, Exatech.
Read More

Other news to note for Oct. 27, 2023

Oct. 27, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clarix Imaging, Laborie Medical Technologies, Pocdoc, Roche Diagnostics, Urotronic, Vital Signs Solutions.
Read More

In the clinic for Oct. 27, 2023

Oct. 27, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards, Heartflow, Magenta Medical, Peijia Medical, Prostatype Genomics, Recor Medical, Personalis, Woebot Labs.
Read More
Previous 1 2 … 555 556 557 558 559 560 561 562 563 … 10249 10250 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing